Tokyo to Bangalore

In the late 1980s to early ’90s it was the information technology (IT) companies from Silicon Valley of USA who moved to Bangalore, and now the University of Tokyo, the oldest of Japanese varsities with several Nobel laureates to its credit, has opened its office in the city of Bangalore, which is nicknamed the Silicon Valley of India.

The actions of Silicon Valley and the University of Tokyo have a common impetus: young talent of India. As I interacted with the Director of Indian Office at the University of Tokyo, Mr. Hoshino, he revealed that the problems plaguing Japan are decreasing population and a declining of interest among its youth for science as a career, which he says is worrisome. With this Bangalore liaison office, he is confident that the well-equipped Japanese universities and laboratories could be a worthy platform for Indian students to get trained, as well as internships and training in India for young Japanese graduates. An interaction between industry and academia is also a goal of the University of Tokyo’s move to Bangalore, he insisted.

The calls to mine the scenario in 1993 when I first landed in Japan, when, except for the Tokyo metropolitan area, the signs in railway stations were in Japanese only.  That has now changed, and the University of Tokyo is also starting to offer programs in English, which will remove the language barrier, enabling Indian students to come to Japan for higher studies and research careers in science.

No doubt, this initiative will be a win-win for both countries: Japanese technology should add value to the Indian talents, and the diverse, big market of India, with its knowledge base should be an ideal platform for the Japanese institutes.

I will not be surprised if a university from India opens an office in Tokyo to lure the Japanese graduates with what India has to offer!

Blog post and artwork by Samuel JK Abraham

Entrepreneurial Events

List of worldwide life science gatherings. Click links for more information.

 

 

 

ICBBS 2012: International Conference on Biotechnology and Biological Sciences

September 12-13, River View Hotel Singapore

https://www.waset.org/conferences/2012/singapore/icbbs/

 

Pharmaceutical Strategic Alliances

September 17-19, Marriott Marquis, New York

https://www.elsevierbi.com/mkt/Conf/PSA/2012AttendingCompanies

 

BioPharm America 2012: 5th Annual International Partnering Conference

September 19-21, Westin Boston Waterfront, Boston

https://www.ebdgroup.com/bpa/index.php

 

BioSpain 2012: 6th International Meeting on Biotechnology

September 19-21, Bilbao Exhibition Centre, Bilbao, Spain

https://www.biospain2012.org/en/index.cfm

 

15th European Congress on Biotechnology

September 23-26, Grand Cevahir Hotel and Convention Center, Istanbul, Turkey

https://www.ecb15.org/

 

Mid-Atlantic Bio

September 27-28, Bethesda North Marriott Hotel and Conference Center, Bethesda, Maryland

https://midatlanticbio.org/

 

The News Net

The News Net returns with a slew of bioentrepreneur news from around the world. This week, Switzerland takes stock after a large shutdown; India, Malaysia and Australia all aim higher; and two new ways to fund your startup. Did we miss anything? Tell us in the comments.
 

  • Merck Serono’s recent decision to close up shop in Geneva has been a shock to western Switzerland. But according to swissinfo.ch, it may generate opportunities for emerging biotech companies. Read why here.

 

  • The Association of Biotech Led Enterprises (ABLE), the Indian biotech industry group, has called for setting up a Rs 5,000 crore (approximately $1.1 billion) biomanufacturing fund, as well as soft loans, larger special economic zones, tax incentives, a simplified regulatory framework and a biosimilars policy as keys to becoming a leader in the biopharma industry. Here’s the full article.

 

  • Technology Park Malaysia Biotech is inviting universities to commercialize their research, signing a memorandum of understanding with University Malaysia Pahang to focus on research into—among other native products—gaharu, a traditional oil used for making perfume, with a view toward commercialization. More details here.

 

  • Meanwhile, in Australia, Starpharma Holdings CEO Jackie Fairley thinks the government should make early-stage funding more attractive to investors, saying the industry would benefit greatly from incentives for investors in the form of tax breaks. Former Queensland premier Peter Beattie also recently urged investors to support emerging industries in the health and life sciences sector. Read more here.

 

  • Crowd funding isn’t just for creative types anymore. On the heels of Kickstarter’s success comes START.ac, a brand new crowdfund site focused squarely on tech startups. Read the Forbes article here.

 

  • Another new company, Gust, offers entrepreneurs a chance to submit funding requests to angel investors around the world. Since launching in September 2011, it currently boasts 35,000 investors on its platform with 185,000 entrepreneurs as registered users. Via Crain’s New York Business.